Beaudet Arthur L, Belmont John W
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030, USA.
Annu Rev Med. 2008;59:113-29. doi: 10.1146/annurev.med.59.012907.101800.
Advances in the fabrication of DNA microarrays as well as transformations in detection chemistries have vastly increased the throughput for genotyping, DNA sequencing, and array-based copy number analysis (ABCNA). Rapid changes in technology are not only affecting research but also revolutionizing DNA diagnostics. Here we focus on the application of high-throughput ABCNA and genotyping. Targeted and genome-wide ABCNA has led to the discovery of extensive DNA copy number variation in the population and the delineation of many previously unrecognized submicroscopic chromosomal aberrations (genomic disorders). High-throughput single-nucleotide polymorphism (SNP) genotyping is being widely applied in genome-wide association studies (GWASs) with recent successes in identification of common variants that confer risk for common adult diseases. Future applications of high-throughput genotyping and array-based DNA sequencing technology will undoubtedly involve research and diagnostic analyses of rare mutations and perhaps ultimately enable full individual genome sequencing.
DNA微阵列制造技术的进步以及检测化学的变革极大地提高了基因分型、DNA测序和基于阵列的拷贝数分析(ABCNA)的通量。技术的快速变化不仅影响研究,也正在彻底改变DNA诊断。在这里,我们重点关注高通量ABCNA和基因分型的应用。靶向和全基因组ABCNA已导致发现人群中广泛的DNA拷贝数变异,并描绘出许多以前未被识别的亚微观染色体畸变(基因组疾病)。高通量单核苷酸多态性(SNP)基因分型正广泛应用于全基因组关联研究(GWAS),最近在识别导致常见成人疾病风险的常见变异方面取得了成功。高通量基因分型和基于阵列的DNA测序技术的未来应用无疑将涉及对罕见突变的研究和诊断分析,也许最终能够实现完整的个人基因组测序。